查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405896

临床实验室测试市场规模、份额和趋势分析报告：按类型、最终用途、按地区、细分市场预测，2024-2030 年

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (Complete Blood Count, HGB/HCT Testing), By End-use (Primary Clinics, Central Laboratories), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 104 Pages | 商品交期: 2-10个工作天内

价格

临床实验室测试市场成长和趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球临床实验室检测市场规模预计将达到2,130.4亿美元，2024年至2030年复合年增长率为9.2%。

临床实验室检测市场的成长归因于目标疾病盛行率的上升。由于将测试用于多种诊断目的，临床实验室测试的使用正在增加，主要关注患者的健康状况，从而评估和製定适当的诊断和治疗。

世界人口老化不断增加，被认为是心血管疾病和肾功能障碍等疾病发展的最大危险因子。据世界卫生组织称，到2030年，60岁及以上的人口预计将达到六分之一，从2020年的10亿增加到2030年的14亿。此外，到2050年，80岁及以上的人口预计将增加一倍，达到15亿以上，80岁及以上的人口预计将增加两倍，达到4,260亿。因此，预计老年人口的增加将在预测期内成为市场的一个有影响力的市场驱动力。

心血管疾病和糖尿病等目标疾病盛行率的增加预计将在整个预测期内提振市场。 CVD 是致命的，也是全世界死亡的主要原因。与心血管疾病相关的大量未满足的医疗需求以及相关的患者意识的提高是预计推动床边血脂检测需求的因素之一。根据世界卫生组织统计，2021年，心血管疾病是过去30年来全球死亡和发病的主要原因，每年有177亿人死于心血管疾病，占17亿人的31%。

此外，参与临床诊断药物开发和配製的主要公司正在专注于合作研究和伙伴关係，以开发新的结核病治疗方法并保持市场竞争力。此外，预计实验室自动化系统的日益采用也将在预测期内推动市场发展。例如，2023年1月，BD推出了第三代整体实验室自动化系统，可实现微生物实验室检体处理的自动化。此外，2023 年 1 月，NovoPath LLC 扩展了其针对肿瘤实验室的 LIS 解决方案。

临床实验室检测市场报告亮点

  • HbA1c 测试领域在 2023 年占据最大的销售份额，这是由于糖尿病人口不断增加。
  • 由于血液相关疾病的盛行率不断增加，预计 HGB/HCT 检测领域在预测期内将呈现最快的成长速度。
  • 由于市场普及和检测量较高，中心实验室领域将在 2023 年占据市场主导地位。
  • 由于监管支持的不断增加和临床测试投资的增加，北美在 2023 年占据了最大的市场占有率。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章临床实验室检测市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 临床实验室测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章临床实验室检测市场：类型估计和趋势分析

  • 类型市场占有率，2023 年和 2030 年
  • 细分仪表板
  • 按类型分類的全球临床实验室检测市场展望
  • 2018年至2030年市场规模、预测与趋势分析如下
    • 血液常规检查
    • HGB/HCT测试
    • 基础代谢小组测试
    • BUN 肌酸酐测试
    • 电解质测试
    • 糖化血红素测试
    • 2018-2030 年市场估计与预测
    • 综合代谢组测试
    • 肝臟检测
    • 肾臟组合测试
    • 血脂检查
    • 心血管小组测试

第五章临床实验室检测市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的全球临床实验室检测市场展望
  • 2018年至2030年市场规模、预测与趋势分析如下
    • 中心实验室
    • 基层诊所

第六章临床实验室检测市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
  • 供应商形势
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023 年主要企业股票分析
    • Abbott
    • CINVEN
    • QUEST DIAGNOSTICS INCORPORATED
    • OPKO HEALTH, INC.
    • F. Laboratory Corporation of America Holdings
    • UNILABS
    • Synnovis Group LLP
    • SONIC HEALTHCARE
Product Code: 978-1-68038-361-4

Clinical Laboratory Tests Market Growth & Trends:

The global clinical laboratory tests market size is expected to reach USD 213.04 billion by 2030, expanding at a CAGR of 9.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the clinical laboratory tests market is attributable to the rising prevalence of target diseases. The use of clinical laboratory tests is on a rise owing to the use of tests in a wide variety of diagnostic purposes that primarily focus on patient health leading to evaluating and formulating proper diagnosis and treatment.

The global geriatric population is increasing and is considered as being the greatest risk factor for the development of conditions, such as cardiovascular diseases and kidney dysfunction. According to WHO, the population aged above 60 years is expected to be 1 in every 6 people by 2030, which accounts for an increase from 1 billion in 2020 to 1.4 billion by 2030. In addition, the number of people aged 80 and above is projected to double to over 1.5 billion by 2050, and people aged above 80 years are expected to triple and reach 426 Billion. Thus, the growing geriatric population is expected to be a high-impact rendering driver for this market over the forecast period.

The growing prevalence of target diseases, such as CVD and diabetes, is anticipated to boost the market over the forecast period. CVD is fatal and leading cause of death worldwide. Presence of high unmet medical needs pertaining to cardiovascular diseases and the subsequent rise in patient awareness are among factors expected to boost the demand for point-of-care lipid testing. According to WHO, in 2021, cardiovascular diseases have been leading cause of mortality and morbidity worldwide in the last three decades, 17.7 Billion people die every year due to cardiovascular diseases, which is 31% of all the deaths worldwide.

Furthermore, key players involved in developing and formulating clinical laboratory tests are focusing on collaborations and partnerships to develop novel tuberculosis therapeutics and to maintain their competitive position in the market. In addition, increasing adoption of laboratory automation systems is expected to boost the market over the forecast period. For instance, in January 2023[, BD launched a third-generation total laboratory automation system, which automates lab specimen processing for microbiology laboratories. Moreover, in January 2023, NovoPath LLC expanded its LIS solutions for oncology laboratories.

Clinical Laboratory Tests Market Report Highlights:

  • HbA1c tests segment held largest revenue share in 2023 and is attributable to the increasing prevalence of diabetic population
  • HGB/HCT tests segment is expected to show fastest growth rate over the forecast period owing to the growing prevalence of blood-related disorders
  • Central laboratories segment dominated the market in 2023 attributable to the high market penetration and procedure volumes
  • North America held the largest market share in 2023 which can be attributed to the growing regulatory support and increase in investments in clinical laboratory tests

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Laboratory Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing geriatric population
      • 3.2.1.2. Growing prevalence of target disease
      • 3.2.1.3. Introduction of innovative solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of ambiguous regulatory framework
      • 3.2.2.2. COVID-19 pandemic
  • 3.3. Clinical Laboratory Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Laboratory Tests Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Complete Blood Count
      • 4.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2. HGB/HCT Testing
      • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.3. Basic Metabolic Panel Testing
      • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.4. BUN Creatinine Testing
      • 4.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.5. Electrolytes Testing
      • 4.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.6. HbA1c Testing
    • 4.4.7. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.8. Comprehensive Metabolic Panel Testing
      • 4.4.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.9. Liver Panel Testing
      • 4.4.9.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.2. Hepatitis
      • 4.4.9.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.3. Bile Duct Obstruction
      • 4.4.9.3.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.4. Liver Cirrhosis
      • 4.4.9.4.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.5. Liver Cancer
      • 4.4.9.5.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.6. Bone Disease
      • 4.4.9.6.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.7. Autoimmune Disorders
      • 4.4.9.7.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
      • 4.4.9.8. Others
      • 4.4.9.8.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.10. Renal Panel Testing
      • 4.4.10.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.11. Lipid Panel Testing
      • 4.4.11.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 4.4.12. Cardiovascular Panel Testing
      • 4.4.12.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Laboratory Tests Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Central Laboratories
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 5.4.2. Primary Clinics
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. CINVEN
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. QUEST DIAGNOSTICS INCORPORATED
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. OPKO HEALTH, INC.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. F. Laboratory Corporation of America Holdings
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. UNILABS
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Synnovis Group LLP
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. SONIC HEALTHCARE
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 3 North America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 4 North America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 5 U.S. clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 Canada clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 8 Canada clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 Europe clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 10 Europe clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Europe clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 12 Germany clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Germany clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 UK clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 15 UK clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 France clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 17 France clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 18 Italy clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Italy clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Spain clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Spain clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 22 Denmark clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Denmark clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Sweden clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Sweden clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26 Norway clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Norway clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 31 China clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 32 China clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Japan clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Japan clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35 India clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 36 India clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 South Korea clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 38 South Korea clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Australia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 40 Australia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Thailand clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 42 Thailand clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America clinical laboratory tests market, by application, 2018 - 2030 (USD Billion)
  • Table 46 Brazil clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 50 Argentina clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 51 Argentina clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 MEA clinical laboratory tests market, by region, 2018 - 2030 (USD Billion)
  • Table 53 MEA clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 54 MEA clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 South Africa clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 56 South Africa clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57 Saudi Arabia clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 59 UAE clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 60 UAE clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)
  • Table 61 Kuwait clinical laboratory tests market, by type, 2018 - 2030 (USD Billion)
  • Table 62 Kuwait clinical laboratory tests market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Clinical laboratory tests market: market outlook
  • Fig. 14 Clinical laboratory tests competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical laboratory tests market driver impact
  • Fig. 20 Clinical laboratory tests market restraint impact
  • Fig. 21 Clinical laboratory tests market strategic initiatives analysis
  • Fig. 22 Clinical laboratory tests market: Type movement analysis
  • Fig. 23 Clinical laboratory tests market: Type outlook and key takeaways
  • Fig. 24 CBC market estimates and forecast, 2018 - 2030
  • Fig. 25 HGB/HCT test market estimates and forecast, 2018 - 2030
  • Fig. 26 Basic metabolic panel market estimates and forecast, 2018 - 2030
  • Fig. 27 BUN creatinine test market estimates and forecast, 2018 - 2030
  • Fig. 28 Electrolyte tests market estimates and forecast, 2018 - 2030
  • Fig. 29 HbA1c tests market estimates and forecast, 2018 - 2030
  • Fig. 30 Comprehensive metabolic panel market estimates and forecast, 2018 - 2030
  • Fig. 31 Liver panel test market estimates and forecast, 2018 - 2030
  • Fig. 32 Hepatitis liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 33 Bile duct obstruction liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 34 Liver cirrhosis liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 35 Liver cancer liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 36 Bone disease liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 37 Autoimmune disorders liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 38 Others liver panel tests market estimates and forecast, 2018 - 2030
  • Fig. 39 Renal panel test market estimates and forecast, 2018 - 2030
  • Fig. 40 Lipid panel tests market estimates and forecast, 2018 - 2030
  • Fig. 41 Cardiovascular panel test market estimates and forecast, 2018 - 2030
  • Fig. 42 Clinical laboratory tests market: End-use movement Analysis
  • Fig. 43 Clinical laboratory tests market: End-use outlook and key takeaways
  • Fig. 44 Central Laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 45 Primary Clinics market estimates and forecasts,2018 - 2030
  • Fig. 46 Global clinical laboratory tests market: Regional movement analysis
  • Fig. 47 Global clinical laboratory tests market: Regional outlook and key takeaways
  • Fig. 48 Global clinical laboratory tests market share and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America: SWOT
  • Fig. 55 Europe SWOT
  • Fig. 56 Asia Pacific SWOT
  • Fig. 57 Latin America SWOT
  • Fig. 58 MEA SWOT
  • Fig. 59 North America, by country
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecasts, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 66 Europe
  • Fig. 67 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 68 UK
  • Fig. 69 UK market estimates and forecasts, 2018 - 2030
  • Fig. 70 Germany
  • Fig. 71 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 72 France
  • Fig. 73 France market estimates and forecasts, 2018 - 2030
  • Fig. 74 Italy
  • Fig. 75 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 76 Spain
  • Fig. 77 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 78 Denmark
  • Fig. 79 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 80 Sweden
  • Fig. 81 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 82 Norway
  • Fig. 83 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 84 Asia Pacific
  • Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 86 China
  • Fig. 87 China market estimates and forecasts, 2018 - 2030
  • Fig. 88 Japan
  • Fig. 89 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 90 India
  • Fig. 91 India market estimates and forecasts, 2018 - 2030
  • Fig. 92 Thailand
  • Fig. 93 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 94 South Korea
  • Fig. 95 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 96 Australia
  • Fig. 97 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 98 Latin America
  • Fig. 99 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 100 Brazil
  • Fig. 101 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 102 Mexico
  • Fig. 103 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 104 Argentina
  • Fig. 105 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 106 Middle East and Africa
  • Fig. 107 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 108 South Africa
  • Fig. 109 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 110 Saudi Arabia
  • Fig. 111 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 112 UAE
  • Fig. 113 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 116 Market share of key market players- Clinical laboratory tests market